Showing results (2491-2500 of 2,656) with videos related to
Sort By:
Pageof 266
Journal of Immunological Methods|March 29, 2021
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patientsA M Cook, S E Faustini, L J Williams, et al.International Journal of Radiation Oncology, Biology, Physics|December 8, 2020
Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor ActivityDaniel A Pomeranz Krummel, Tahseen H Nasti, Milota Kaluzova, et al.Biorxiv : the Preprint Server for Biology|December 11, 2023
GABA(A) receptor activation drives GABARAP-Nix mediated autophagy to radiation-sensitize primary and brain-metastatic lung adenocarcinoma tumorsDebanjan Bhattacharya, Riccardo Barille, Donatien Kamdem Toukam, et al.Bioorganic & Medicinal Chemistry|November 23, 2020
C-2 derivatized 8-sulfonamidoquinolines as antibacterial compoundsEmma K Davison, John E McGowan, Freda F Li, et al.Journal of Medicinal Chemistry|February 27, 2018
Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced BioavailabilityDaniel E Knutson, Revathi Kodali, Branka Divović, et al.Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitorsJ Nicole Hamblin, Tony D R Angell, Stuart P Ballantine, et al.ARKIVOC : Free Online Journal of Organic Chemistry|August 11, 2020
Synthesis of chiral GABAA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depressionGuanguan Li, Michael R Stephen, Revathi Kodali, et al.Microbiology Resource Announcements|December 22, 2023
From compost to culver: genome sequence and annotation of a cluster CQ1 Gordonia phageWilliam K Alexander, Rianna R Allen, Jaden D Anderson, et al.Nature Communications|January 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosisIsabel K Barter, Max J Bedding, Julia Leodolter, et al.The Lancet. Oncology|September 5, 2020
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-inAnna K Nowak, W Joost Lesterhuis, Peey-Sei Kok, et al.Pageof 266